Beck Capital Management’s Merck MRK Stock Holding History

Beck Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,277	Closed	-$815K	–	109
2019 Q1	$815K	Buy	10,277 +4,361	+74%	+$326K	0.39%	63
2018 Q4	$431K	Buy	+5,916	New	+$418K	0.37%	45
2016 Q1	–	Sell	-3,279	Closed	-$165K	–	128
2015 Q4	$165K	Buy	+3,279	New	+$165K	0.1%	119

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Beck Capital Management's MRK Position: Q2 2019 in Review

Beck Capital Management sold out of Merck (MRK) in Q2 2019, closing a stake of 10,277 shares — an estimated $815K sold.

Beck Capital Management first reported a position in MRK in Q4 2015 and held it in 3 quarters. The position peaked at $815K in Q1 2019. 2,299 funds tracked by Wall St. Rank hold MRK as of Q2 2019.

Beck Capital Management reported no remaining Merck position as of Q2 2019 after selling out during the quarter.
Beck Capital Management sold 10,277 Merck shares in Q2 2019, an estimated $815K.
Beck Capital Management first reported a position in Merck in Q4 2015 and held it in 3 quarters.
Beck Capital Management's Merck position peaked at $815K in Q1 2019.
2,299 funds tracked by Wall St. Rank held Merck as of Q2 2019.

Based on Beck Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.